Table 5.
Effects of bempedoic acid on cardiovascular outcomes.
| Review | Effect estimate (95% CI) |
| Cardiovascular mortality | |
| Goyal et al.21 | RR = 0.81, CI 0.61–1.08 |
| De Filippo et al.26 | OR = 1.04, CI 0.88–1.24 |
| Zhang et al.24 | RR = 1.05, CI 0.89–1.24 |
| Lin et al.28 | OR = 1.66, CI 0.45–6.04 |
| Wang et al.33 | RR = 1.65, CI 0.46–5.98 |
| MACE | |
| Tenorio et al.20 | RR = 0.86, CI 0.80–0.94 |
| Goyal et al.21 | RR = 0.81, CI 0.61–1.08 |
| Venkatraman et al.23 | RR = 0.88, CI 0.77–0.99 |
| Zhang et al.24 | RR = 0.86, CI 0.87–0.94 |
| Uddin et al.25 | RR = 0.87, CI 0.80–0.94 |
| De Filippo et al.26 | OR = 0.86, CI 0.79–0.95 |
| Mutschlechner et al.27 | OR = 0.84, CI 0.76–0.96 |
| Lin et al.28 | OR = 0.85, CI 0.61–1.15 |
| Wang et al.33 | RR = 0.75, CI 0.56–0.99 |
| Khan et al.35 | RR = 0.82, CI 0.61–1.11 |
| Bhagavathula et al.32 | RR = 0.34, CI 0.04–3.17 |
| MI | |
| Goyal et al.21 | RR = 0.76, CI 0.66–0.88 |
| Li et al.22 | OR = 0.76, CI 0.65–0.90 |
| De Filippo et al.26 | OR = 0.76, CI 0.64–0.88 |
| Wang et al.33 | RR = 0.54, CI 0.25–1.15 |
| Unstable angina | |
| Goyal et al.21 | RR = 0.67, CI 0.50–0.88 |
| Zhang et al.24 | RR = 0.70, CI 0.55–0.89 |
| De Filippo et al.26 | OR = 0.69, CI 0.54–0.88 |
| Uddin et al.25 | RR = 0.69, CI 0.54–0.88 |
| Lin et al.28 | OR = 0.94, CI 0.51–1.74 |
| Wang et al.33 | RR = 0.84, CI 0.41–1.73 |
| Coronary revascularization | |
| Goyal et al.21 | RR = 0.81, CI 0.66–0.99 |
| Zhang et al.24 | RR = 0.82, CI 0.73–0.92 |
| De Filippo et al.26 | OR = 0.81, CI 0.71–0.92 |
| Uddin et al.25 | RR = 0.82, CI 0.73–0.92 |
| Lin et al.28 | OR = 0.82, CI 0.55–1.22 |
| Wang et al.33 | RR = 0.74, CI 0.50–1.10 |
| Coronary non-revascularization | |
| Uddin et al.25 | RR = 0.41, CI 0.18–0.96 |
| Lin et al.28 | OR = 0.41, CI 0.18–0.95 |
RR: risk ratio, OR: odd ratio, CI: confidence interval, MACE: major cardiovascular events.